Designed to expand to every demand, the GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) offers proven procedural success and long-term outcomes 1-3 through flexibility, strength and accuracy to treat aortoiliac occlusive disease.

View catalogue numbers and specifications, like introducer sheath size and guidewire diameter, for the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis.

The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is indicated for the treatment of de novo or restenotic lesions found in iliac arteries with reference vessel diameters ranging from 5mm -...

The GORE VBX FORWARD clinical study aims to demonstrate the superiority of the GORE VIABAHN VBX Balloon Expandable Endoprosthesis (VBX device) for primary patency when compared to bare metal stenting (BMS) for the treatment of complex iliac artery occlusive disease.

Designed to expand to every demand, the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) offers proven procedural success and long-term outcomes through flexibility, strength and accuracy to treat aortoiliac occlusive disease. Indicated to treat broad vascular anatomy.

Nov 1, 2021 · Results: VBX covered stent was used in 231 patients. Key patient characteristics include mean age of 73.4 ± 9 years, 77% male, 45% diabetes, and 18% suffering from end-stage renal dysfunction on dialysis. TASC II CD lesions were observed in 51% patients, which included 81% calcified lesions.

Secondary balloon required to post-dilate the stent beyond its nominal deployed diameter (secondary balloon not included). Technical limit of the device. Expansion beyond 13 mm is outside of the indication − see Instructions For Use.

The VBX stent used as bridging stent for BEVAR in this cohort demonstrates sustained, good performance at 3 years. In particular, we report an excellent patency for the SMA and CT with low rate of restenosis or instability.

In this study, we report on two patients with CRA caused by intermittent claudication (IC) who underwent endovascular VIABAHN VBX balloon-expandable stent-graft (VVBX) placement. Both patients underwent successful endovascular VVBX placement via transfemoral artery approach, and hemostasis was achieved via vascular closure device.

In this case, due to VBX Stent Graft compatibility with a 6 Fr sheath, diagnostic pigtail catheter access was maintained throughout all portions of the case which contributed to successful deployment of the stent graft, obviating the need for hand-held retrograde injections from the treatment side. Utilizing the contralateral side for